Speciality European Pharma divests Speciality European Pharma International and strengthens focus on urology
30 April 2008
Read full article
SEP to divest Haemopressin business in order to focus on urology
28 March 2008
Read full article
Speciality European Pharma launches Plenaxis® in Germany
25 February 2008
Read full article
Distribution rights secured for Amphocil® for leading European markets
13 July 2007
Read full article
Two major acquisitions and closing of €15m financing round
5 February 2007
Advent creates speciality pharma company
14 September 2006
Read full article
A GREAT START
Founded in 2006, Speciality European Pharma has already acquired a portfolio of marketed or regulatory stage products and is seeking further opportunities for Europe.
For the latest developments, please click to view the press releases, left.
Can't find what you're looking for? Try our Site Map
site design: www.message-design.co.uk
